MDL Judge Dismisses Zantac Litigation, After Excluding Expert Testimony on Cancer Risk
Plaintiffs plan to appeal the decision, maintaining that there is more than sufficient evidence about the link between Zantac and cancer to allow juries to consider lawsuits